Fast Five Quiz: Type 2 Diabetes and Hypertension

Romesh Khardori, MD, PhD

Disclosures

February 22, 2022

As stated in a position statement from the American Diabetes Association, many studies have shown that antihypertensive therapy reduces atherosclerotic cardiovascular disease events, microvascular complications, and heart failure in people with diabetes. Addressing multiple risk factors simultaneously has been shown to confer significant benefits. Data suggest that atherosclerotic cardiovascular disease morbidity and mortality have decreased for people with diabetes since 1990, which is probably due in large part to improvements in blood pressure control.

Combination therapy is frequently needed for the management of hypertension. Patients with diabetes should be treated similarly to those without diabetes unless proteinuria is present, in which case combination therapy should include an angiotensin-converting enzyme inhibitor or angiotensin receptor blocker.

Learn more about improving outcomes in people with type 2 diabetes.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

processing....